Immunotherapy and lung cytopathology: Overview and possibilities

The pathological diagnosis of lung cancer has become a multistep process. Advances in next-generation sequencing (NGS) and other high-throughput genomic profiling platforms have transformed the classification of lung cancer from histopathological descriptions to precise molecular and genetic identities, thereby providing the rationale for therapeutic strategies and the roadmap for the treatment plan.

Más información